Parathyroid cancer is rare, but often fatal, as preoperative identification of malignancy
against the backdrop of benign parathyroid disease is challenging. Advanced genetic …

Parathyroid carcinoma is one of the least common endocrine malignancies, and accounts
for approximately 1% of all patients with primary hyperparathyroidism. A systematic review of …

Parathyroid cancer is one of the rarest causes of primary hyperparathyroidism and tends to
present with more severe symptoms than its more benign counterparts. This article details …

Parathyroid carcinoma is a malignant neoplasm affecting 0.5 to 5.0% of all patients suffering
from primary hyperparathyroidism. This cancer continues to cause challenges for diagnosis …

Purpose Parathyroid cancer is rare and often has a poor outcome. There is no classification
system that permits prediction of outcome in patients with parathyroid cancer. This study was …

The diagnosis of parathyroid carcinoma can be challenging, and adjuvant therapies such as
radiotherapy and chemotherapy are not particularly beneficial in the management of this …

Background Parathyroid cancer is rare and often fatal. This review provides an in-depth
analysis of 330 clinical cases reported in detail. These data are used to inform a proposal for …

Parathyroid carcinoma (PC) is usually associated with severe symptomatic primary
hyperparathyroidism (PHPT) and accounts for less than 1% of all cases of PHPT and …

Parathyroid carcinoma is a rare form of endocrine malignancy accounting for only a small
minority of cancer cases. Due to the rarity of this cancer, there are no generalized guidelines …

Background Parathyroid carcinoma is a rare disease. Conflicting results on prognostic
factors and extent of surgical resection for patients with parathyroid carcinoma have been …